Cat's claw and cancer care
What 3 graded rows on cat's claw agree on for cancer care, and where they differ. Counted side by side, never averaged.
Consensus finder Rows from the Cat's claw page, reviewed Oct 21, 2026 How it decides
What the rows agree on
Each block and row is one graded row from the Cat's claw page, with its PubMed record.
Your question
Cat's claw and cancer care
3 rows · 134 peopleMostly an improvement: 2 of 3 rows, and most of the people. 1 found no difference.
- DGrade D× 3
- Rows
- 3
- Trials
- 3
- People
- 134
Where they differ
From the rowsThe best-graded row, grade D, is an open-label trial of 51 people (2015) and found an improvement.
Only the 2 rows that found an improvement name women in their population.
The rows
2 improved · 1 no difference- DGrade DQuality of life and fatigue in advanced cancer · Improved
Open-label trial · n 51 · 2015 · Adults with advanced solid tumours and no further treatment options (Brazil)
100 mg three times daily (300 mg/day) · Not stated in the abstract
Overall quality of life, social functioning and fatigue scores improved; inflammatory markers did not change and no tumour responses were seen.
- DGrade DNeutropenia during breast-cancer chemotherapy · Improved
RCT · n 40 · 2012 · Women with stage II invasive ductal breast cancer on FAC chemotherapy (Brazil)
300 mg/day · 6 chemotherapy cycles
Neutropenia caused by chemotherapy was smaller in the cat's claw group than in the chemotherapy-only control group.
- DGrade DBlood counts and side effects during colorectal-cancer chemotherapy · No difference
RCT · n 43 · 2012 · Adults with colorectal cancer on FOLFOX4 chemotherapy (Brazil)
300 mg/day · 6 chemotherapy cycles
No change in blood counts, oxidative-stress or immune markers, or adverse events versus chemotherapy alone; no toxic effects.